Advanced search
Publication Cover
Journal of Chemotherapy Volume 35, 2023 - Issue 1
Submit an article Journal homepage
186
Views
6
CrossRef citations to date
0
Altmetric
Anticancer Original Research Papers

CircRNA_001895 promotes sunitinib resistance of renal cell carcinoma through regulation of apoptosis and DNA damage repair

Lei Tana Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaView further author information
,
Zehai Huanga Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaView further author information
,
Zerong Chena Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaView further author information
,
Shijun Chena Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaView further author information
,
Yunlin Yeb Department of Urology, Cancer Center, Sun Yat-Sen University and State Key Laboratory of Oncology in Southern China, Guangzhou, ChinaView further author information
,
Tong Chena Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaView further author information
&
Zhuangfei Chena Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 11-18 | Received 12 Aug 2021, Accepted 18 Nov 2021, Published online: 20 Dec 2021

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: A Cancer J Clin. 2020;70(1):7–30.
  • Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ. 2014;349:g4797.
  • Choueiri TK, Motzer RJ. Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med. 2017;376(4):354–366.
  • Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2007;356(2):125–134.
  • Atkins MB, Tannir NM. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma. Cancer Treat Rev. 2018;70:127–137.
  • Qu L, Ding J, Chen C, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29(5):653–668.
  • Molina AM, Lin X, Korytowsky B, et al. Sunitinib objective response in metastatic renal cell carcinoma: analysis of 1059 patients treated on clinical trials. Eur J Cancer. 2014;50(2):351–358.
  • Rini BI, Atkins MB. Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol. 2009;10(10):992–1000.
  • Geng Y, Jiang J, Wu C. Function and clinical significance of circRNAs in solid tumors. J Hematol Oncol. 2018;11(1):98.
  • Li J, Huang C, Zou Y, et al. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p. Mol Cancer. 2020;19(1):103.
  • Hua X, Sun Y, Chen J, et al. Circular RNAs in drug resistant tumors. Biomed Pharmacother. 2019;118:109233.
  • Mirzaei S, Zarrabi A, Hashemi F, et al. Regulation of nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: inhibiting or promoting carcinogenesis? Cancer Lett. 2021;509:63–80.
  • Chen Z, Xiao K, Chen S, et al. Circular RNA hsa_circ_001895 serves as a sponge of microRNA‐296‐5p to promote clear cell renal cell carcinoma progression by regulating SOX12. Cancer Sci. 2020;111(2):713–726.
  • Zhang Z, Li H, Zhao Y, et al. Asporin promotes cell proliferation via interacting with PSMD2 in gastric cancer. Front Biosci. 2019;24:1178–1189.
  • Xu T, Wang M, Jiang L, et al. CircRNAs in anticancer drug resistance: recent advances and future potential. Mol Cancer. 2020;19(1):127.
  • Chen Y-L, Ge G-J, Qi C, et al. A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma. J Cell Physiol. 2018;233(10):6649–6660.
  • Gámez-Pozo A, Antón-Aparicio LM, Bayona C, et al. MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients. Neoplasia. 2012;14(12):1144–1152.
  • Xing Q, Li R, Xu A, et al. Genetic variants in a long noncoding RNA related to sunitinib resistance predict risk and survival of patients with renal cell carcinoma. Cancer Med. 2019;8(6):2886–2896.
  • Liu Y, Cheng G, Huang Z, et al. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma. Cell Death Dis. 2020;11(7):515.
  • Li L-Y, Guan Y-D, Chen X-S, et al. DNA repair pathways in cancer therapy and resistance. Front Pharmacol. 2021;11:629266.
  • Devin J, Denis Q, Bret C, et al. Targeting DNA repair to overcome drug resistance in Hodgkin lymphoma. Blood. 2020;136(Supplement 1):26–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.